Wednesday, July 16, 2014 12:31:25 AM
re;
It's just nice to see the word Cannabinoid coming from a real biopharmaceutical company trading on the nasdaq and not some fly by night OTC stock that suddenly pulls the word out of thin air because their business as an auto repair shop wasn't working out. ;)
I am skeptical that it would be, or become, anything like Sativex
but I am very curious to learn where this patent will take them, what it will bring into the pipeline, and what APD371 is really about.
Quote:
--------------------------------------------------------------------------------
APD371, an orally available agonist of the CB2 receptor, is an internally discovered investigational drug candidate Arena is exploring for several potential indications, including chronic pain.
This compound is designed to be highly selective to provide pain relief without psychotropic effects and without the potential for dependence or abuse.
Preclinical efficacy with APD371 has been shown in animal models of pain.
--------------------------------------------------------------------------------
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM